Neuraxis stockholders elect all six director nominees, approve equity plan amendments at annual meeting

Neuraxis, INC

Six director nominees elected: Brian Carrico, Dr. Christopher R Brown, Bradley Mitch Watkins, Beth Keyser, Kristen Ferge, Dr. Gilad Aharon; each received 96-99% of votes.
Ratification of Rosenberg Rich Baker Berman as independent auditor for FY 2026 approved (10,187,191 votes for, 0 against, 16,815 abstentions).
Third amendment to Neuraxis 2022 Omnibus Securities and Incentive Plan (solely Section 5.1) approved with 6,730,816 votes for, 727,030 against.
Neuraxis 2025 Employee Stock Purchase Plan approved as amended; Section 5(c) changed to 10% ownership limit from 5%.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Neuraxis, INC shareholders approved Amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan at the 2026-06-10 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

3. The proposal regarding the amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan was approved as follows:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Neuraxis, INC shareholders approved Approval of Neuraxis, Inc. 2025 Employee Stock Purchase Plan at the 2026-06-10 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

4. The proposal regarding the Neuraxis, Inc. 2025 Employee Stock Purchase Plan was approved as follows:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Neuraxis, INC shareholders approved Ratification of appointment of Rosenberg Rich Baker Berman, P.A. as independent registered public accounting firm at the 2026-06-10 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

2. The proposal to ratify the appointment of Rosenberg Rich Baker Berman, P.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as follows:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Neuraxis, INC shareholders approved Election of six nominees for director at the 2026-06-10 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

1. The six nominees for director were elected to serve a one-year term as follows:

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Neuraxis, INC filing history →

Source: SEC EDGAR

accession 0001493152-26-028489

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.